Stephanie Okey

CIK 1742616 · last filed 2026-03-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.06M

Companies

4

Total Filings

36

Lifetime Open-Market Net

-$2.89M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PTCT Director 8,000 $75.14 $601.1K -$1.96M 16 2026-03-12
CRNX Director 13,300 $34.47 $458.5K -$930.7K 9 2026-03-04
Catalent, Inc. (CTLT) Delisted Director 0 $63.48 $0 $0 4 2024-12-18
ALBIREO PHARMA, INC. (ALBO) Delisted Director $44.15 $0 7 2023-03-02

Recent Filings · Page 2 of 4

36 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-06-11 CRNX Grant (A) +3,400 $0 EDGAR
2024-04-02 CRNX Mixed -$491.6K EDGAR
2024-02-16 PTCT Grant (A) +4,000 $0 EDGAR
2023-10-31 Catalent, Inc. (CTLT) Delisted Grant (A) +6,993 $0 EDGAR
2023-08-30 Catalent, Inc. (CTLT) Delisted Grant (A) +979 $0 EDGAR
2023-06-21 CRNX Grant (A) +6,000 $0 EDGAR
2023-03-02 ALBIREO PHARMA, INC. (ALBO) Delisted Disp (D) $0 EDGAR
2023-01-09 PTCT Grant (A) +4,000 $0 EDGAR
2022-08-11 PTCT Sell (S) −2,296 -$118.5K EDGAR
2022-06-28 ALBIREO PHARMA, INC. (ALBO) Delisted Grant (A) $0 EDGAR
Showing 1120 of 36
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.